| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.008 |